Afuco™ Anti-Human HCV-E2 ADCC Therapeutic Antibody (HuMax-HepC), ADCC Enhanced
Anti-HCV-E2 ADCC Enhanced Antibody (HuMax-HepC) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a fully human therapeutic monoclonal antibody targeting the E2 envelope protein of the Hepatitis C Virus (HCV). It is a promising candidate for the development of immunoprophylaxis against HCV infection.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-331CL |
| Pricing | Inquiry |
| Host | Human |
| Target | HCV-E2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |